Divi’s Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold?

Divi’s Labs surged 6% after reporting a 64% YoY profit jump in Q3FY25. Revenue rose 25% YoY to Rs 2,319 crore. Goldman Sachs stays Neutral (target: Rs 5,925), while Nuvama maintains Buy (target: Rs 6,830) citing strong growth potential. Divi’s Labs surged 6% after reporting a 64% YoY profit jump in Q3FY25. Revenue rose 25% YoY to Rs 2,319 crore. Goldman Sachs stays Neutral (target: Rs 5,925), while Nuvama maintains Buy (target: Rs 6,830) citing strong growth potential.  Economic Times